Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats

Journal of Neuroendocrinology

Volumn 8, Issue 5, 1996, Pages 337-343

  Baker, Ross A ^a   Herkenham, Miles ^a   Brady, Linda S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Arcuate; Fluoxetine; Idazoxan; Imipramine; NPY; Phenelzine; POMC

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; IDAZOXAN; IMIPRAMINE; MESSENGER RNA; NEUROPEPTIDE Y; PHENELZINE; PROOPIOMELANOCORTIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NERVE CELL; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ARCUATE NUCLEUS; FLUOXETINE; GENE EXPRESSION; IDAZOXAN; IMAGE PROCESSING, COMPUTER-ASSISTED; IMIPRAMINE; IN SITU HYBRIDIZATION; MALE; NEUROPEPTIDE Y; PHENELZINE; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS;

EID: 0029925027     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.04422.x     Document Type: Article

References (50)

1. Brady LS, Whitfield HJ, Fox RJ, Gold PW, Herkenham M. (1991). Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Investigation. 87: 831-837.
2. Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield HJ. (1992). The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res. 572: 117-125.
3. Gold PW, Goodwin FK, Chrousos GP. (1988). Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress. New Engl J Med. 319: 348-353 and 413-420.
4. Young EA, Haskett RF, Murphy-Weinberg V. Watson SJ. Akil H. (1991). Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry. 48: 693-699.
5. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. (1994). Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60: 436-444.
6. Barden N, Reul JMHM, Holsboer F. (1995). Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18: 6-11.
7. Blier P, de Montigny C. (1994). Current advances and trends in the treatment of depression. Trends in Pharm Sciences. 15: 220-226.
8. Sawchenko PE. Imaki T, Potter E, Kovács K, Imaki J, Vale WW. (1993). The functional neuroanatomy of corticotropin-releasing factor. In: Chadwick DJ, Marsh J, Ackrill K, eds. Ciba Found Symp. 172: Corticotropin Releasing Factor, 5-21. John Wiley and Sons, New York.
9. Whitnall MH. (1993). Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol. 40: 573-629.
10. Fuxe K, Wikstrom A-C, Okret S, Agnati LF, Harfstrand A, Yu Z-Y, Granholm L, Zoli M, Vale W, Gustafsson J-A. (1985). Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology. 177: 1803-1812.
11. Aronsson M, Fuxe K, Dong Y, Agnati LF, Okret S, Gustafsson J-A. (1988). Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proc Nat Acad Sciences (USA). 85: 9331-9335.
12. Baker RA, Herkenham M. (1995). Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol. 358: 518-530.
13. Hisano S, Kagotani Y, Tsuruo Y, Daikoku S, Chihara K, Whitnall MH. (1988). Localization of glucocorticoid receptor in neuropeptide Y-containing neurons in the arcuate nucleus of the rat hypothalamus. Neurosci Letts. 95: 13-18.
14. Cintra A, Fuxe K, Solfrini V, Agnati LF, Tinner B, Wikstrom A-C, Staines W, Okret S, Gustafsson J-A. (1991). Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons. J Steroid Biochem Molec Biol. 40: 93-103.
15. Widerlöv E, Lindström LH, Whalestedt C, Ekman R. (1988). Neuropeptide Y and peptide YY as possible cerebrospinal markers for major depression and schizophrenia, respectively. J Psychiatr Res. 22: 69-79.
16. Heilig M, Widerlöv E. (1990). Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatrie illnesses. Acta Psychiatr Scand. 82: 95-114.
17. Nemeroff CB, Bissette G, Akil H, Fink M. (1991). Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy: corticotrophin-releasing factor, β-endorphin and somatostatin. Br J Psych. 158: 59-63.
18. Heilig M, Wahlestedt C, Ekman R, Widerlöv E. (1988). Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur J Pharm. 147: 465-467.
19. Smialowska M, Legutko B. (1991). Influence of imipramine on neuropeptide Y immunoreactivity in the rat brain. Neuroscience. 41: 767-771.
20. Brady LS. (1994). Stress, antidepressant drugs, and the locus coruleus. Brain Res Bull. 35: 545-556.
21. Smith MS, Brady LS, Glowa J, Gold PW, Herkenham M. (1991). Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization. Brain Res, 544: 26-32.
22. Akabayashi A, Watanabe Y, Wahlestedt C, McEwen BS, Paez X, Leibowitz SF. (1994). Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res. 665: 201-212.
23. Mamalaki E, Kvetnansky R, Brady LS, Gold PW, Herkenham M. (1992). Repeated immobilization stress alters tyrosine hydroxylase, corticotropin-releasing hormone and corticosteroid receptor messenger ribonucleic acid levels in rats brain. J Neuroendocrinol. 4: 689-699.
24. Zaborszky L. (1982). Afferent connections of the mediobasal hypothalamus. Adv Anat Embryol Cell Biol. 69: 1-102.
25. Chronwall BM. (1985). Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides. 6 Suppl. 2: 1-11.
26. Sim LJ, Joseph SA. (1991). Arcuate nucleus projections to brainstem regions which modulate nociception. J Chem Neuroanat. 4: 97-109.
27. Liposits Z, Seivers L, Paull WK. (1988). Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat: an immunocytochemical analysis at the light and electron microscopic levels. Histochemistry. 88: 227-234.
28. de Quidt ME, Kiyama H, Emson P. (1990). Pancreatic polypeptide, neuropeptide Y and peptide YY in central neurons. In: Björklund A, Hökfelt T, Kuhar M, eds. Handbook of Chemical Neuroanatomy: Neuropeptides in the CNS, Part 11, 287-357. Elsevier, Amsterdam.
29. Khachaturian H, Lewis ME, Tsou K, Watson SJ. (1985). β-endorphin. α-MSH, ACTH and related peptides. In: Björklund A, Hökfelt T, eds. Handbook of Chemical Neuroanatomy: GABA and neuropeptides in the CNS, Part I, 216-272. Elsevier, Amsterdam.
30. Joseph SA, Michael GJ. (1988). Efferent ACTH-IR opiocortin projections from nucleus tractus solitarius: a hypothalamic deafferentation study. Peptides. 9: 193-201.
31. Cunningham ET, Sawchenko PE. (1988). Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol. 274: 60-76.
32. Plotsky PM, Cunningham ET, Widmaier EP. (1989). Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrine Rev. 10: 437-458.
33. Liposits Z. (1990). Ultrastructural immunocytochemistry of the hypothalamic corticotropin releasing hormone synthesizing system: Anatomical basis of neuronal and humoral regulatory mechanisms. Progr Histochem Cytochem. 21: 1-95
34. Cullinan WE, Herman JP, Watson SJ. (1993). Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol. 332: 1-20.
35. Ericsson A, Kovacs KJ, Sawchenko PE. (1994). A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress related neuroendocrine neurons. J Neurosci. 14: 897-913.
36. Herman JP, Cullinan WE, Watson SJ. (1994). Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J Neuroendocrinol. 6: 433-442.
37. Willoughby JO, Blessing WW. (1987). Origin of serotonin innervation of the arcuate and ventromedial hypothalamic region. Brain Res. 418: 170-173.
38. 1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 561: 51-60.
39. Scheinin M, Lomasney JW, Hayden-Hixson DM, Schambra UB, Caron MG, Lefkowitz RJ, Fremeau RTJ. (1994). Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Mol Brain Res. 21: 133-149.
40. 2 receptor subtype mRNAs in rat brain. J Comp Neurol. 351: 357-373.
41. Chaput Y, de Montigny C, Blier P. (1991). Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. Neuropsychopharm. 5: 219-229.
42. Lacroix D, Blier P, Curet O, de Montigny C. (1991). Effects of longterm desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. J Pharm Exp Therapeut. 257: 1081-1090.
43. Gjerris A, Widerlöv E, Werdelin L, Ekman R. (1992). Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J Psychiatr Neurosci. 17: 23-27.
44. Berrettini WH, Doran AR, Kelsoe J, Roy A, Pickar D. (1987). Cerebrospinal fluid neuropeptide Y in depression and schizophrenia. Neuropsychopharm. 1: 81-83.
45. Drouin J, Chamberland M, Charron J, Jeannotte L, Nemer M. (1985). Structure of the rat pro-opiomelanocortin (POMC) gene. FEBS Lett. 193: 54-58.
46. Larhammer DL, Ericsson A, Persson H. (1987). Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci. (USA). 84: 2068-2072.
47. Jingami H, Mizuno N, Takahashi H, Shibahara S, Furutani Y, Imura H, Numa S. (1985). Cloning and sequence analysis of cDNA for rat corticotropin-releasing factor precursor. FEBS Lett. 191: 63-66.
48. Brady LS, Smith MA, Gold PW, Herkenham M. (1990). Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food deprived rats. Neuroendocrinology. 52: 441-447.
49. Herkenham M, Pert CB. (1982). Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality. J Neurosci. 2: 1129-1149.
50. Herkenham M. (1988). Influence of tissue treatment on receptor autoradiography. In: van Leeuwen FW, Buijs RM, Pool CW, Pach O, eds. Molecular Neuroanatomy, 111 120. Elsevier, New York.